PRENETICS GLOBAL LTD-CL A (PRE)
KYG722451229 - Common Stock
Let's take a look at the stocks that are in motion in today's session.
Which stocks are experiencing notable movement on Wednesday?
PRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023
PRE stock results show that Prenetics Global beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
HONG KONG, April 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health...
Prenetics Global Non-Cumulative Redeemable Preferred Shares, Series J Shares Cross 6% Yield Mark
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
(From left: Dr. Ghada Alsaleh, Sonia Pawelczyk, Danny Yeung, Dr. James L. Green, Ahmed Alfandi, Dr. Tara Ruttley, Wasim Ahmed, Dr. Hilde Stenuit, Dr....
Prenetics Global files to sell 1.48M Class A shares for holders (NASDAQ:PRE)
The selling stockholders of Prenetics Global (NASDAQ:PRE) plan to offer and sell up to 1.48 million Class A shares of the company, the company disclosed in...
Prenetics Announces Third Quarter 2023 Financial Results
Prenetics Announces Third Quarter 2023 Financial Results
HONG KONG, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health...
Prenetics Global announces reverse stock split (NASDAQ:PRE)
Prenetics Global (PRE) Wednesday announced that it will proceed with a reverse stock split of its outstanding ordinary shares at a ratio of 1-for-15. The revers
Prenetics Global Limited Announces Reverse Stock Split
Prenetics Global Limited Announces Reverse Stock Split
HONG KONG, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading-genomics-driven health sciences company today announced...
Prenetics Global's Preferred Shares, Series J Crosses Above 7% Yield Territory
Prenetics Announces Second Quarter 2023 Financial Results
Prenetics Announces Second Quarter 2023 Financial Results
HONG KONG, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health...
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV
Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor Dennis Lo. The new JV will be called Insighta and Yeung will serve as its first CEO. Yeung reveals plans to launch tests targeting lung and liver cancer in 2025, with a goal of selling over 30 million tests annually by 2030.
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT...
Prenetics Announces First Quarter 2023 Financial Results
Prenetics Announces First Quarter 2023 Financial Results
HONG KONG, June 05, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision...
7 Stocks to Buy for Their Massive Upside Potential
While blue chips are relatively predictable, they’re also boring. For serious gains, you need to check out these stocks to buy now.
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision Oncology
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision Oncology...